The Comparison of Effects of Applications of Compound 48/80 and Mast Cell Mediator Suspension on Inflammation in Rats: A Methodological Study for Acute Inflammatory Painin
We aimed to compare effects of administrations of the compound-48/80 and mast cell mediator suspension (MCMS) obtained from peritoneal MCs on the inflammation in rats.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: Inflammation underlies the pathological basis of most diseases.
📊
Key Findings & Data:Substance-P is a key mediator that participates in various inflammatory processes and painful conditions.
💡
Conclusion & Impact:We aimed to compare effects of administrations of the compound-48/80 and mast cell mediator suspension (MCMS) obtained from peritoneal MCs on the inflammation in rats.
Objective: Inflammation underlies the pathological basis of most diseases. Substance-P is a key mediator that participates in various inflammatory processes and painful conditions. Mast cells (MCs) have a key role in inflammatory processes via mediators released from their granules. The experimental models for the investigation of pathogenesis and treatment of inflammatory diseases represent merely certain characteristics of inflammatory cases, therefore, more comprehensive models are required. We aimed to compare effects of administrations of the compound-48/80 and mast cell mediator suspension (MCMS) obtained from peritoneal MCs on the inflammation in rats.
KİLİNC, E., DAGİSTAN, Y., CETİNKAYA, A., TORE, F. (2019). The Comparison of Effects of Applications of Compound 48/80 and Mast Cell Mediator Suspension on Inflammation in Rats: A Methodological Study for Acute Inflammatory Painin. Clinical and Experimental Health Sciences, Cilt: 9 - Sayı: 1, 34–41. https://ajindex.com/articles/481728
Schlereth T, Birklein F. Mast cells: source of inflammation in complex regional pain syndrome? Anesthesiol. 2012; 116:756-7
Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A, Kalogeromitros D. Mast cells and inflammation. Biochim. Biophys. Acta 2012; 1822:21-33
Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Therianou A, Kalogeromitros D, Theoharides TC. Mast cells in allergic and inflammatory diseases. Curr. Pharm. Des. 2012;18:2261-2277
Kilinc E, Dagistan Y, Kukner A, Yilmaz B, Agus S, Soyler G, Tore F. Salmon calcitonin ameliorates migraine pain through modulation of CGRP release and dural mast cell degranulation in rats. Clin. Exp. Pharmacol. Physiol. 2018; 45(6):536-546
Kilinc E, Dagistan Y, Tore F. Mast cell degranulation mediates compound 48/80-induced meningeal vasodilatation underlying migraine pain. Clin. Exp. Health Sci. 2017; 196-201
Aich A, Afrin LB, Gupta K. Mast cell-mediated mechanisms of nociception. Int. J. Mol. Sci. 2015;16:29069-29092
Héron A, Dubayle D. A focus on mast cells and pain. J. Neuroimmunol. 2013;264:1-7
Manchanda RK, Jaggi AS, Singh N. Ameliorative potential of sodium cromoglycate and diethyldithiocarbamic acid in restraint stress-induced behavioral alterations in rats. Pharmacol. Rep. 2011;63:54-63
Finn DF, Walsh JJ. Twenty-first century mast cell stabilizers. Br. J. Pharmacol.2013;170:23-37. [10] da Silva EZ, Jamur MC, Oliver C. Mast cell function: a new vision of an old cell. J. Histochem. Cytochem. 2014;62:698-738
Bozic CR, Lu B, Höpken UE, Gerard C, Gerard NP. Neurogenic amplification of immune complex inflammation. Science 1996;273:1722-5
Lisowska B, Lisowski A, Siewruk K. Substance P and chronic pain in patients with chronic inflammation of connective tissue. PLoS One 2015;10:e0139206
Straub RH, Cutolo M. Involvement of the hypothalamicpituitary- adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum. 2001;44:493-507
Clay F, Morris C. British inflammation research association meeting: is there any point in developing an anti-RA drug? National Heart and Lung Institute, London, UK, 21-22 November 1996. Inflamm. Res. 1997;46:243-245
Gabrielian L, Helps SC, Thornton E, Turner RJ, Leonard AV, Vink R. Substance P antagonists as a novel intervention for brain edema and raised in